Galmed Pharmaceuticals Ltd.
GLMD
$4.63
$0.8121.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.23M | 15.45M | 18.16M | 19.05M | 20.53M |
| Total Receivables | 323.00K | 451.00K | 80.00K | 549.00K | 433.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 267.00K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 159.00K | 125.00K | 124.00K | 124.00K | 123.00K |
| Total Current Assets | 11.71M | 16.03M | 18.63M | 19.72M | 21.08M |
|
|
|||||
| Total Current Assets | 11.71M | 16.03M | 18.63M | 19.72M | 21.08M |
| Net Property, Plant & Equipment | 164.00K | -- | -- | -- | -- |
| Long-term Investments | 1.76M | -- | -- | -- | -- |
| Goodwill | 1.76M | -- | -- | -- | -- |
| Total Other Intangibles | 4.64M | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 267.00K | 267.00K |
| Total Assets | 18.28M | 16.03M | 18.63M | 21.58M | 22.94M |
|
|
|||||
| Total Accounts Payable | 1.90M | 1.72M | 2.00M | 1.67M | 1.37M |
| Total Accrued Expenses | -- | -- | 840.00K | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 83.00K | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 834.00K | 355.00K | 2.00K | 798.00K | 1.05M |
| Total Other Current Liabilities | 834.00K | 355.00K | 2.00K | 798.00K | 1.05M |
| Total Current Liabilities | 2.81M | 2.08M | 2.85M | 2.47M | 2.42M |
|
|
|||||
| Total Current Liabilities | 2.81M | 2.08M | 2.85M | 2.47M | 2.42M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 46.00K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.69M | -- | -- | -- | -- |
| Total Liabilities | 5.55M | 2.08M | 2.85M | 2.47M | 2.42M |
|
|
|||||
| Common Stock & APIC | 228.48M | 227.02M | 226.86M | 225.39M | 224.99M |
| Retained Earnings | -215.41M | -212.69M | -210.78M | -205.96M | -204.07M |
| Treasury Stock & Other | -331.00K | -383.00K | -303.00K | -316.00K | -403.00K |
| Total Common Equity | 12.74M | 13.95M | 15.78M | 19.11M | 20.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.74M | 13.95M | 15.78M | 19.11M | 20.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.74M | 13.95M | 15.78M | 19.11M | 20.52M |
|
|
|||||